Beacon Therapeutics Holdings Limited
- Company number
- 14303840
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 18 Aug 2022
- Nature of business
- Research and experimental development on biotechnology
Registered office
Previous names
- SPL 123 Limited (until 1 Jun 2023)
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BALDO, Lance | Director | 3 Oct 2024 | |
| CHESTER, Cariad Dixon | Director | 3 Jul 2024 | |
| HRISTODOROV, Dimitrij, Dr | Director | 3 Jul 2024 | |
| JOUSTRA, Wouter Sebastian James | Director | 3 Jul 2024 | |
| FAROOQ, Khurem Arif | Director | 1 May 2023 | |
| FELLOWS, David Andrew | Director | 31 Mar 2023 | |
| PETRIS, Elisa Michela, Dr | Director | 18 Aug 2022 | |
| HOLLOWOOD, Christopher John, Dr | Director | 18 Aug 2022 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Syncona Limited | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
18 Aug 2022 |
Accounts
| Year ended |
|---|
| 31 Dec 2025 |
| 31 Dec 2024 |
| 31 Dec 2023 |
Connections
Controls
- Beacon Therapeutics Limited (14426488)
Directors’ other companies
- FAROOQ, Khurem Arif - Director at Verdiva Bio Limited
- HOLLOWOOD, Christopher John, Dr - Director at Syncona Investment Management Limited
Companies at the same address
- Beacon Therapeutics Limited (14426488)
- Pacific Biosciences UK, Ltd (07285032)